Is Ultrasound-Guided Steroid Injection Less Effective in Carpal Tunnel Syndrome Patients with Bifid Median Nerve?
1 other identifier
observational
50
1 country
1
Brief Summary
The aim of this study is to evaluate the short-term efficacy of ultrasound-guided corticosteroid injection in patients with and without bifid median nerve.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2024
CompletedFirst Posted
Study publicly available on registry
October 24, 2024
CompletedStudy Start
First participant enrolled
October 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2025
CompletedJanuary 20, 2025
January 1, 2025
3 months
October 22, 2024
January 16, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Visual Analog Scale (VAS):
The Visual Analog Scale is a widely used tool to assess the intensity of pain. It consists of a straight line, typically 10 cm in length, where one end represents "no pain" (0) and the other end represents "worst imaginable pain" (10). Patients mark a point on the line that corresponds to their current level of pain. VAS provides a simple, quantitative measure of pain that is easy for patients to use and for clinicians to interpret, making it a reliable tool for tracking changes in pain levels over time.
0 day, 4th week
Boston Carpal Tunnel Syndrome Questionnaire Symptom Severity Scale (BCTQ-SSS):
The SSS assesses the severity of carpal tunnel symptoms such as pain, tingling, and numbness. The total score for this scale ranges from a minimum of 11 to a maximum of 55. A lower score indicates mild or no symptoms, while a higher score suggests more severe symptoms. As the score increases, the severity of symptoms worsens, with a score closer to 55 reflecting a significantly greater impact on daily life.
0 day, 4th week
Quick Disabilities of the Arm, Shoulder, and Hand Questionnaire (Quick-DASH):
The Quick-DASH is a shortened version of the full DASH questionnaire, designed to measure physical function and symptoms in people with musculoskeletal disorders of the upper limb. It consists of 11 items that assess the difficulty a patient experiences in performing activities of daily living, such as carrying a heavy object, opening a jar, or using a computer. Each item is scored on a 5-point Likert scale, where higher scores reflect greater disability. The Quick-DASH is a validated, efficient tool that provides a broad overview of the patient's upper extremity function and how their condition affects daily life.
0 day, 4th week
Boston Carpal Tunnel Syndrome Questionnaire Functional Status Scale (BCTQ-FSS):
The FSS evaluates how carpal tunnel syndrome affects a person's ability to perform daily tasks like writing, buttoning clothes, or holding objects. The total score for this scale ranges from a minimum of 8 to a maximum of 40. A lower score suggests little to no difficulty in performing these tasks, while a higher score reflects greater functional limitations. As the FSS score increases, it indicates that the condition is having a more pronounced effect on daily functioning.
0 day, 4th week
Study Arms (2)
Bifid median nerve
Patients (diagnosed with carpal tunnel syndrome) with bifid median nerve
Control group
Patients (diagnosed with carpal tunnel syndrome) with normal median nerve
Interventions
Eligibility Criteria
Patients with mild to moderate carpal tunnel syndrome
You may qualify if:
- Patients aged 18-65.
- Diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies conducted within the last 6 months.
- Scheduled for ultrasound-guided corticosteroid injection.
- Patients who have agreed to participate in the study.
You may not qualify if:
- Diagnosis of any other condition that could cause neuropathic symptoms, such as polyneuropathy, brachial plexopathy, or thoracic outlet syndrome.
- Previous history of injection or surgery for carpal tunnel syndrome
- Patients who refuse to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beylikdüzü State Hospital
Istanbul, Beylikdüzü, 34147, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
October 22, 2024
First Posted
October 24, 2024
Study Start
October 25, 2024
Primary Completion
January 15, 2025
Study Completion
January 15, 2025
Last Updated
January 20, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share